Insider Transactions in Q4 2024 at Halozyme Therapeutics, Inc. (HALO)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 29
2024
|
Connie Matsui |
SELL
Bona fide gift
|
Direct |
10,470
-5.41%
|
-
|
|
Nov 29
2024
|
Helen Torley PRESIDENT AND CEO |
SELL
Bona fide gift
|
Direct |
10,000
-1.48%
|
-
|
|
Oct 16
2024
|
Michael J. La Barre SVP, CHIEF TECHNICAL OFFICER |
SELL
Open market or private sale
|
Direct |
10,000
-5.44%
|
$530,000
$53.26 P/Share
|
|
Oct 16
2024
|
Michael J. La Barre SVP, CHIEF TECHNICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+5.16%
|
$190,000
$19.98 P/Share
|
|
Oct 15
2024
|
Michael J. La Barre SVP, CHIEF TECHNICAL OFFICER |
SELL
Open market or private sale
|
Direct |
10,000
-2.72%
|
$530,000
$53.99 P/Share
|
|
Oct 15
2024
|
Michael J. La Barre SVP, CHIEF TECHNICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+2.68%
|
$180,000
$18.32 P/Share
|
|
Oct 09
2024
|
Helen Torley PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
10,000
-0.49%
|
$530,000
$53.02 P/Share
|
|
Oct 09
2024
|
Helen Torley PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+1.44%
|
$130,000
$13.87 P/Share
|
|
Oct 08
2024
|
Helen Torley PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
10,000
-0.73%
|
$540,000
$54.25 P/Share
|
|
Oct 08
2024
|
Helen Torley PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+1.44%
|
$130,000
$13.87 P/Share
|